Literature DB >> 32015869

Hepatitis C Virus in Egypt: Interim Report From the World's Largest National Program.

Wael Abdel-Razek1, Mohamed Hassany2, Manal Hamdy El-Sayed3, Magdy El-Serafy4, Wahid Doss4, Gamal Esmat4, Imam Waked1.   

Abstract

Entities:  

Year:  2020        PMID： 32015869      PMCID： PMC6988418          DOI： 10.1002/cld.868

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  6 in total

Review 1.  Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-12-16

2.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.

Authors:  Richard K Sterling; Eduardo Lissen; Nathan Clumeck; Ricard Sola; Mendes Cassia Correa; Julio Montaner; Mark S Sulkowski; Francesca J Torriani; Doug T Dieterich; David L Thomas; Diethelm Messinger; Mark Nelson
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

3.  One step closer to elimination of hepatitis C in Egypt.

Authors:  Gamal Esmat; Manal Hamdy El-Sayed; Mohamed Hassany; Wahid Doss; Imam Waked
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-10

Review 4.  The current and future disease burden of chronic hepatitis C virus infection in Egypt.

Authors:  Imam Waked; Waheed Doss; Manal Hamdy El-Sayed; Chris Estes; Homie Razavi; Gamal Shiha; Ayman Yosry; Gamal Esmat
Journal:  Arab J Gastroenterol       Date:  2014-06-06       Impact factor: 2.076

5.  Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience.

Authors:  Aisha Elsharkawy; Maissa El-Raziky; Wafaa El-Akel; Kadry El-Saeed; Rasha Eletreby; Mohamed Hassany; Manal Hamdy El-Sayed; Khaled Kabil; Sohier A Ismail; Magdy El-Serafy; Ashraf Omar Abdelaziz; Mohamed Kamal Shaker; Ayman Yosry; Wahid Doss; Yehia El-Shazly; Gamal Esmat; Imam Waked
Journal:  J Hepatol       Date:  2017-12-06       Impact factor: 25.083

6.  High efficacy of generic and brand direct acting antivirals in treatment of chronic hepatitis C.

Authors:  Mai Abozeid; Ayman Alsebaey; Eman Abdelsameea; Warda Othman; Mostafa Elhelbawy; Amr Rgab; Marwa Elfayomy; Tamer Samir Abdel-Ghafar; Mervat Abdelkareem; Alyaa Sabry; Marwa Fekry; Nashwa Shebl; Eman Rewisha; Imam Waked
Journal:  Int J Infect Dis       Date:  2018-08-02       Impact factor: 3.623
  6 in total
  5 in total

Review 1.  Genomics in Egypt: Current Status and Future Aspects.

Authors:  Eman Ahmed El-Attar; Rasha Mohamed Helmy Elkaffas; Sarah Ahmed Aglan; Iman S Naga; Amira Nabil; Hoda Y Abdallah
Journal:  Front Genet       Date:  2022-05-13       Impact factor: 4.772

2.  Egypt's Ambitious Strategy to Eliminate Hepatitis C Virus: A Case Study.

Authors:  Ahmed Hassanin; Serageldin Kamel; Iman Waked; Meredith Fort
Journal:  Glob Health Sci Pract       Date:  2021-03-31

3.  Usability and acceptability of self-testing for hepatitis C virus infection among the general population in the Nile Delta region of Egypt.

Authors:  Elena Ivanova Reipold; Ahmed Farahat; Amira Elbeeh; Reham Soliman; Elkin Bermudez Aza; Muhammad S Jamil; Cheryl Case Johnson; Gamal Shiha; Philippa Easterbrook
Journal:  BMC Public Health       Date:  2021-06-22       Impact factor: 3.295

Review 4.  Innovations in Hepatitis C Screening and Treatment.

Authors:  Arpan A Patel; Aileen Bui; Eian Prohl; Debika Bhattacharya; Su Wang; Andrea D Branch; Ponni V Perumalswami
Journal:  Hepatol Commun       Date:  2020-12-07

5.  HCV genome-wide analysis for development of efficient culture systems and unravelling of antiviral resistance in genotype 4.

Authors:  Long V Pham; Martin Schou Pedersen; Ulrik Fahnøe; Carlota Fernandez-Antunez; Daryl Humes; Kristian Schønning; Santseharay Ramirez; Jens Bukh
Journal:  Gut       Date:  2021-04-08       Impact factor: 23.059
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.